Effects of the Feeding Length of Spent Mushroom Composts from Selenium-Enriched Mushroom on Selenium Deposition in Finishing Hanwoo Steers

셀레늄강화 버섯폐배지의 급여기간이 거세한우의 조직내 셀레늄축적에 미치는 영향

This study was carried out to determine effects of the feeding length of spent mushroom composts from selenium-enriched mushroom (Se-SMC) on muscular selenium deposition in finishing Hanwoo steers. A total of 30 steers were allotted to an experiment with a 3 × 2 factorial arrangement. Treatments were 2 groups of with and without Se-SMC at three different feeding lengths (2, 4, and 6 months) by body weight (BW). And then dry matter intake, body weight gain, Se concentration and/or content in blood and/or muscle were investigated. Dry matter intake was not affected by feeding length and Se-SMC supplementation. As the feeding length was prolonged, initial and final BW was significantly lowered (p<0.01) with no Se-SMC effect. However, total BW gain was significantly increased (p<0.0001) with increasing feeding length with no effect of Se-SMC. Se-SMC supplementation significantly increased Se concentration in whole blood, but there was no effect on feeding length. Se contents in muscles, especially hind-leg, were significantly increased (p<0.05) as the feeding length was increased. However, there was no difference for Se content between four and six months feeding groups of Se-SMC and also hepatic Se content was not affected by feeding length. On the contrast, hepatic Se content for Se-SMC group within each feeding length was significantly increased (p<0.001) compared with no Se-SMC supplementation. In conclusion, our results suggested that optimum feeding length of Se-SMC as a strategy for the production of Se-fortified beef might be approximately 4 months.

본 연구는 사료내 적정 셀레늄수준(0.9ppm)에서 Se-SMC(유기셀레늄강화버섯폐배지)의 급여사양기간(2개월, 4개월, 6개월)을 달리 했을 때, 비육후기 한우의 조직 내 셀레늄함량에 미치는 영향을 조사하여 최대포화축적기간을 제시하고자 실시하였다. Se-SMC 급여기간에 따른 비육후기 한우의 건물섭취량은 급여기간과 셀레늄수준에 의하여 처리구 간에 유의한 차이가 나타나지 않았고, 셀레늄이 사료섭취의 제한요인으로 나타나지 않았다. 또한, 사양시험 개시체중과 종료체중은 급여기간이 증가함에 따라 유의하게 낮았다(p<0.01). 하지만, 총 증체량은 급여기간이 증가함에 따라 유의하게 증가하였으나(P<0.0001), Se-SMC에 의한 효과 또한 나타나지 않았다. 한편, 사료내 셀레늄수준은 한우의 혈중 셀레늄농도를 유의하게 증가시켰으나(p<0.0001), 급여기간에 따른 효과는 나타나지 않았다. 등심내 셀레늄함량은 급여기간과 사료내 셀레늄수준에 의하여 유의한 효과가 나타나지 않았다. 후지내 셀레늄함량은 급여기간이 증가함에 따라 유의하게 증가하였으나(p<0.05), Se-SMC의 4개월 급여군과 6개월 급여군간에는 유의한 차이가 나타나지 않았다. 간내 셀레늄함량은 급여기간의 효과는 나타나지 않았지만, 셀레늄효과는 대조구에 비하여 유의하게 증가하였다(p<0.0001). 따라서, 본 연구에서 근육내 셀레늄에 대한 Se-SMC급여기간은 4개월 정도가 적당할 것으로 생각된다.